48.9600.73% ( -0.360 )
Delay Closed: Nov 16, 16:08:11Financials
Q3 FY2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: HENGRUI PHARMA(01276) the Revenue is 10.48 B (+29.04%), Beat estimate;the EBIT is 3.317 B (+107.1%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
10.48B29.04%
10.42B28.37%
+0.05B0.67%
EBITExceed expectations
3.32B107.05%
3.01B87.93%
+0.31B19.12%
EPS
TBA--
0.325--
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 25, 2027
Estimate Revenue39.53 B
Estimate EBIT--
Estimate EPS1.6058
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
